| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/09/2003 | US6617331 Purine inhibitors of protein kinases, G proteins and polymerases |
| 09/09/2003 | US6617329 Aminoquinazolines and their use as medicaments |
| 09/09/2003 | US6617328 Sustained release ranolazine formulations |
| 09/09/2003 | US6617327 For therapy of depression and other diseases such as obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders |
| 09/09/2003 | US6617326 Imidazo-triazine derivatives as ligands for GABA receptors |
| 09/09/2003 | US6617325 Biphenyl derivatives, production thereof and uses as medicines |
| 09/09/2003 | US6617324 Substituted pyrazoles as p38 kinase inhibitors |
| 09/09/2003 | US6617322 Administering a piperazine or piperidine coupled through a linker to a benzhydril |
| 09/09/2003 | US6617321 2-methyl-thieno-benzodiazepine formulation |
| 09/09/2003 | US6617320 Protease inhibitor; anticoagulants |
| 09/09/2003 | US6617319 Animal extracts; uterine contractions; isolation by distillation, flash chromatography |
| 09/09/2003 | US6617318 7-substitted tetracyclines are effective against tetracycline-resistant E. coli, S. aureus and E. faecalis strains |
| 09/09/2003 | US6617317 Boronic ester and acid compositions |
| 09/09/2003 | US6617315 Therapeutic compounds |
| 09/09/2003 | US6617314 Injectable formulations of avermectins and milbemycins |
| 09/09/2003 | US6617313 2,6-dihydroxy-2-(P-hydroxybenzyl)-3(2H)benzofuran-7-C-beta -D-glucopyranoside, obtained by solvent extraction of powdered hardwood of Pterocarpus marsupium; treatment of diabetes |
| 09/09/2003 | US6617307 Useful for treatment of fractures, as a filler in deficient sites of bone, for inhibition of decrease in bone substance related to osteoporosis and periodontic diseases |
| 09/09/2003 | US6617305 Stable aqueous dispersion of nutrients |
| 09/09/2003 | US6617157 Using inactivating agent of given formula to inactivate any virus contained in donor blood, blood products, or other biological compositions; can also use in vaccines |
| 09/09/2003 | US6617135 Multiple cytokine protein complexes |
| 09/09/2003 | US6617129 Isolated nucleic acid; prostate-specific gene therapy method; diagnosis and treatment of prostate cancer |
| 09/09/2003 | US6617110 Cultured cell comprising a nucleic acid sequence, encoding the protein, that hybridizes to a polynucleotide of given sequence; use to determine if drug is cytotoxic; can use as anticarcinogenic agent |
| 09/09/2003 | US6616945 Method for making a pharmaceutical formulation |
| 09/09/2003 | US6616943 Composition comprising Wenguanguo extracts and methods for preparing same |
| 09/09/2003 | US6616941 Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof |
| 09/09/2003 | US6616940 Feeding said animal an effective amount of Vitamin A for a time sufficient to reduce adiposity; pet foods |
| 09/09/2003 | US6616939 Lactose or glucose and a mineral supplement ensuring restoration of digestive losses; efficient quantity of soluble vegetable proteins and vegetable lipids ensuring suitable appropriate energy intake. |
| 09/09/2003 | US6616938 Method of making chewing gum containing colloidal bismuth subcitrate |
| 09/09/2003 | US6616933 Excitatory amino acid inhibitors for treating sensitive skins |
| 09/09/2003 | US6616921 Antiperspirant products |
| 09/09/2003 | US6616919 1,1,1-tris(2-methyl-4-hydroxy-5-tert-butylphenyl)butane |
| 09/09/2003 | US6616913 Composition and method for treatment of otitis media |
| 09/09/2003 | CA2360287C Crystalline base of citalopram |
| 09/09/2003 | CA2304096C Sustained-release liposomal anesthetic compositions |
| 09/09/2003 | CA2290712C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components |
| 09/09/2003 | CA2269031C Treatment of urinary incontinence and compositions for use therein |
| 09/09/2003 | CA2263566C Substituted 6,5-hetero-bicyclic derivatives |
| 09/09/2003 | CA2248953C Novel benzofuranone derivatives and process for producing the same |
| 09/09/2003 | CA2244867C Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant |
| 09/09/2003 | CA2239498C Bioartificial devices and cellular matrices therefor |
| 09/09/2003 | CA2228655C Preparation of triazoles by organometallic addition to ketones |
| 09/09/2003 | CA2183834C Antihypertensive agents containing pyrazolopyrimidine derivatives |
| 09/09/2003 | CA2183155C Naphthylisoquinoline alkaloids, pharmaceutical compositions containing them and their use for the treatment of malaria |
| 09/09/2003 | CA2138026C Novel 1,4-dihydroquinoxaline-2,3-diones and uses therefor as glycine receptor antagonists |
| 09/09/2003 | CA2130174C 4-oxo-2 thioxoimidazolidine derivatives as inhibitors of blood platelet aggregation |
| 09/09/2003 | CA2087298C Bile acid sulfurated derivatives |
| 09/09/2003 | CA2085230C Process for activating reproduction of seasonal breeding animals by administering l-dihydroxyphenylalanine (l-dopa) |
| 09/09/2003 | CA2079413C Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use |
| 09/09/2003 | CA2078814C Substituted pyridinylamino-1h-indoles, 1h-indazoles, 2h-indazoles, benzo[b]thiophenes and 1,2-benzisothiazoles, a process for their preparation and their use as medicaments |
| 09/09/2003 | CA2037114C N-cycloalkylalkylamines, their process of preparation, their use as medication and their synthetic intermediates |
| 09/09/2003 | CA2036770C Inhibitors of nitric oxide biosynthesis |
| 09/09/2003 | CA2031480C Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity |
| 09/07/2003 | CA2412065A1 Use of agent for suppressing infection and proliferation of human immunodeficiency syndrome virus |
| 09/04/2003 | WO2003072824A1 Markers for predicting pathological conditions in haert failure and method of using the same |
| 09/04/2003 | WO2003072802A2 Carboxyfullerenes and methods of use thereof |
| 09/04/2003 | WO2003072784A1 Delta 6-desaturases from primulaceae, expressing plants and pufa-containing oils |
| 09/04/2003 | WO2003072779A1 Method of using pituitary-specific genes |
| 09/04/2003 | WO2003072757A2 Nucleotide mimics and their prodrugs |
| 09/04/2003 | WO2003072737A2 Biological inhibitions induced by contact inhibitory factor |
| 09/04/2003 | WO2003072734A2 Bipolar trans carotenoid salts and their uses |
| 09/04/2003 | WO2003072732A2 Methods of making hypermutable cells using pmsr homologs |
| 09/04/2003 | WO2003072711A2 Method of using modified oligonucleotides for hepatic delivery |
| 09/04/2003 | WO2003072704A2 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 09/04/2003 | WO2003072607A1 Monoclonal antibodies that are cross-reactive against bacterial collagen binding proteins |
| 09/04/2003 | WO2003072595A2 Methods and products based on oligomerization of stress proteins |
| 09/04/2003 | WO2003072591A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(2-methoxyl)ethyl modifications |
| 09/04/2003 | WO2003072588A1 Macrolides with antibacterial activity |
| 09/04/2003 | WO2003072582A1 Novel cephalosporin compounds and process for preparing the same |
| 09/04/2003 | WO2003072580A1 1-[ALKYL], 1-[HETEROARYL)ALKYL] AND 1-[ARYL)ALKYL]-7-(PYRIMIDIN-4-YL)-IMADAZO[1,2-a]PYRIMIDIN-5(1H)-ONE DERIVATIVES |
| 09/04/2003 | WO2003072579A1 HETEROARYL SUBSTITUTED 2-PYRIDINYL AND 2-PYRIMIDINYL -6,7,8,9- TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES |
| 09/04/2003 | WO2003072578A1 Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity |
| 09/04/2003 | WO2003072577A1 Thiazole derivatives as npy receptor antagonists |
| 09/04/2003 | WO2003072576A2 Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| 09/04/2003 | WO2003072575A1 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents |
| 09/04/2003 | WO2003072574A1 Piperidine ouracil used as a medicament for treating bacterial infections |
| 09/04/2003 | WO2003072573A1 Crystal forms of (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol |
| 09/04/2003 | WO2003072572A1 Beta3-adrenergic receptor agonists |
| 09/04/2003 | WO2003072570A1 Antidiabetic agents |
| 09/04/2003 | WO2003072569A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 09/04/2003 | WO2003072566A1 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders |
| 09/04/2003 | WO2003072565A1 Process for the production of citalopram |
| 09/04/2003 | WO2003072561A1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 09/04/2003 | WO2003072559A1 Method for producing 3-amidinophenylalanine derivatives |
| 09/04/2003 | WO2003072558A2 Arylsulfone derivatives |
| 09/04/2003 | WO2003072557A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 09/04/2003 | WO2003072556A1 Glutaminyl based dpiv inhibitors |
| 09/04/2003 | WO2003072555A1 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments |
| 09/04/2003 | WO2003072553A1 N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials |
| 09/04/2003 | WO2003072552A1 Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide |
| 09/04/2003 | WO2003072551A1 Uracil-thioether |
| 09/04/2003 | WO2003072550A1 Novel fused ring indazole compounds |
| 09/04/2003 | WO2003072549A1 Farnesyl protein transferase inhibitors as antitumor agents |
| 09/04/2003 | WO2003072548A1 Pyridyl sulfone derivatives as 5-ht receptor antagonists |
| 09/04/2003 | WO2003072547A1 PROCESSES AND INTERMEDIATES USEFUL IN PREPARING β3-ADRENERGIC RECEPTOR AGONISTS |
| 09/04/2003 | WO2003072545A1 Cyclic amine compound and ccr3 inhibitory drug containing the same as active ingredient |
| 09/04/2003 | WO2003072544A1 Crystalline anhydrous and monohydrate benzoate salts of (2's,3s)-3-hydroxy-n-{2{n-methyl-n-4-(n-propylamino-carbonyl)phenyl]amino-2-phenyl}-ethylpyrrolidine |
| 09/04/2003 | WO2003072539A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 09/04/2003 | WO2003072535A2 Substituted hydroxyethylamines |
| 09/04/2003 | WO2003072532A1 Ester compound and medicinal use thereof |
| 09/04/2003 | WO2003072528A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |